Position in COGT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,685,873
+$25,427 QoQ
Shares Held
121,082
0.0% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#130
of 321 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $5,486,611,234 across 68 Biotechnology names. COGT ranks #60 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
2,035,986 | $681,627,752 | |
| 2 | SYRE |
Spyre Therapeutics, Inc.
|
4,319,496 | $383,484,854 | |
| 3 | CELC |
Celcuity Inc.
|
3,197,200 | $334,491,064 | |
| 4 | ASND |
Ascendis Pharma A/S
|
1,163,721 | $310,387,665 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,586,295 | $287,156,333 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
8,085,461 | $286,144,464 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
14,106,187 | $263,926,758 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
3,752,574 | $213,183,728 |
All Filings in COGT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,685,873 | 121,082 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,660,446 | 121,082 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $4,300,832 | 121,082 | Shares | Sole | 2026-02-17 | |
| 2024-03-31 | $5,935,997 | 883,333 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $6,602,993 | 1,122,958 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $22,517,332 | 2,309,470 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $31,488,124 | 2,659,470 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $24,626,275 | 2,282,324 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $37,078,017 | 3,207,441 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $47,855,019 | 3,207,441 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $27,862,527 | 3,088,972 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $23,883,737 | 3,188,750 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $27,359,475 | 3,188,750 | Shares | Sole | 2022-04-13 | |
| 2021-09-30 | $26,817,387 | 3,188,750 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $25,860,762 | 3,188,750 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $27,997,225 | 3,188,750 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $35,809,662 | 3,188,750 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 UMRX | — | 7,955,000 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||